Brief: FDA Approves First Acellular Tissue Engineered Vessel To Treat Vascular Trauma In Extremities
Dec 20 (Reuters) - FDA:
* FDA APPROVES FIRST ACELLULAR TISSUE ENGINEERED VESSEL TO
TREAT
VASCULAR TRAUMA IN EXTREMITIES
* FDA: GRANTED APPROVAL OF SYMVESS TO HUMACYTE GLOBAL INC
Further company coverage: HUMA.O
(((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary